| 1 | namely | 2,201 |
| 2 | besides | 1,940 |
| 3 | notably | 1,660 |
| 4 | beside | 231 |
| 5 | notwithstanding | 181 |
| 6 | viz. | 90 |
| 7 | melsungen | 19 |
| 8 | heptachlor | 13 |
| 9 | cij-3-2f | 8 |
| 10 | eryngium | 7 |
| 11 | a+/a- | 6 |
| 12 | antony | 6 |
| 13 | nontender | 6 |
| 14 | 5,6-eet | 5 |
| 15 | estromineral | 5 |
| 16 | filipinos | 5 |
| 17 | githago | 5 |
| 18 | hirsch | 5 |
| 19 | ng/ml·h | 5 |
| 20 | np25 | 5 |
| 21 | 4rcts | 4 |
| 22 | boehringer-ingelheim | 4 |
| 23 | dover | 4 |
| 24 | less-lethal | 4 |
| 25 | non-sporulating | 4 |
| 26 | ongoing/delivered | 4 |
| 27 | placebo-matched | 4 |
| 28 | ros5 | 4 |
| 29 | amnioscopy | 3 |
| 30 | antiadrenergics | 3 |
| 31 | appending | 3 |
| 32 | arg300 | 3 |
| 33 | azd2858 | 3 |
| 34 | b-9-3 | 3 |
| 35 | brat-mediated | 3 |
| 36 | cefalosporines | 3 |
| 37 | ethylparaben | 3 |
| 38 | fakes | 3 |
| 39 | famously | 3 |
| 40 | favus | 3 |
| 41 | galanthamin* | 3 |
| 42 | geomagic | 3 |
| 43 | gualou | 3 |
| 44 | high-oil | 3 |
| 45 | il1b-511 | 3 |
| 46 | j.b. | 3 |
| 47 | j.p. | 3 |
| 48 | knitting | 3 |
| 49 | lilopristone | 3 |
| 50 | mahwah | 3 |
| 51 | minami | 3 |
| 52 | møller | 3 |
| 53 | nceo2-m | 3 |
| 54 | non-consulted | 3 |
| 55 | o-tyrosine | 3 |
| 56 | repackaged | 3 |
| 57 | rsbv | 3 |
| 58 | secant | 3 |
| 59 | smad-1/-5/-8 | 3 |
| 60 | step-up/over | 3 |
| 61 | styrax | 3 |
| 62 | vp1.15 | 3 |
| 63 | www.clincaltrials.gov | 3 |
| 64 | 'arginine | 2 |
| 65 | 'labour | 2 |
| 66 | 'testosterone | 2 |
| 67 | -480 | 2 |
| 68 | 1,650°c | 2 |
| 69 | 1.09-3.03 | 2 |
| 70 | 10.478 | 2 |
| 71 | 14-3-3μ-1 | 2 |
| 72 | 2'-deoxyadenosine | 2 |
| 73 | 2-4.99 | 2 |
| 74 | 2-hydroxy-4-methoxybenzaldehyde | 2 |
| 75 | 2-moderate | 2 |
| 76 | 2-secondary | 2 |
| 77 | 2.061 | 2 |
| 78 | 200j | 2 |
| 79 | 3-ost-5 | 2 |
| 80 | 5,859 | 2 |
| 81 | 6,900 | 2 |
| 82 | 84:16 | 2 |
| 83 | 8br-camp | 2 |
| 84 | aa/ga | 2 |
| 85 | afe-0602 | 2 |
| 86 | agaricales | 2 |
| 87 | airex | 2 |
| 88 | apolipoprotein-a | 2 |
| 89 | azorellanol | 2 |
| 90 | bilthoven | 2 |
| 91 | brachial-knee | 2 |
| 92 | brownianism | 2 |
| 93 | bsb-33 | 2 |
| 94 | butanaldehyde | 2 |
| 95 | caism/unicamp | 2 |
| 96 | caki-2 | 2 |
| 97 | cd200r | 2 |
| 98 | cd8+cd3+ | 2 |
| 99 | continenticola | 2 |
| 100 | cyclind2 | 2 |
| 101 | d67n | 2 |
| 102 | delphinapterus | 2 |
| 103 | delta-t | 2 |
| 104 | demark | 2 |
| 105 | diafiltered | 2 |
| 106 | dpb1 | 2 |
| 107 | eloasthmin | 2 |
| 108 | etiology/harm | 2 |
| 109 | fam102a | 2 |
| 110 | fluidigm | 2 |
| 111 | free-contact | 2 |
| 112 | gb31 | 2 |
| 113 | gnawing | 2 |
| 114 | graviola | 2 |
| 115 | gsk1360707 | 2 |
| 116 | high-residue | 2 |
| 117 | hot-extruded | 2 |
| 118 | hyponosognosic | 2 |
| 119 | implementation-focused | 2 |
| 120 | inhibitor-kappabalpha | 2 |
| 121 | inodilation | 2 |
| 122 | interphasal | 2 |
| 123 | is20 | 2 |
| 124 | isomontanolide | 2 |
| 125 | isrctn08609907 | 2 |
| 126 | isrctn51688713 | 2 |
| 127 | ixerisoside | 2 |
| 128 | kineflex/c | 2 |
| 129 | l428 | 2 |
| 130 | leary | 2 |
| 131 | light-chain-only | 2 |
| 132 | limpidity | 2 |
| 133 | lineage-negative | 2 |
| 134 | low-sfa | 2 |
| 135 | ltpd471-626 | 2 |
| 136 | maplike | 2 |
| 137 | minibestest | 2 |
| 138 | mono-arthritis | 2 |
| 139 | monoselect | 2 |
| 140 | mpa-glucuronide | 2 |
| 141 | mtor-driven | 2 |
| 142 | n.u. | 2 |
| 143 | newell | 2 |
| 144 | nlrp1 | 2 |
| 145 | non-aluminium | 2 |
| 146 | non-fumigatus | 2 |
| 147 | noneuphoric | 2 |
| 148 | ns-t-c₃₈₀ | 2 |
| 149 | observer-independent | 2 |
| 150 | optical-fiber-based | 2 |
| 151 | p.asp845glu | 2 |
| 152 | polymorphum | 2 |
| 153 | post-measles | 2 |
| 154 | post-thc | 2 |
| 155 | premera | 2 |
| 156 | punjab-96 | 2 |
| 157 | r1441c/g/h | 2 |
| 158 | rahimi | 2 |
| 159 | rarb | 2 |
| 160 | resented | 2 |
| 161 | rs2728127 | 2 |
| 162 | rs28357094 | 2 |
| 163 | rs9138 | 2 |
| 164 | selenoneine | 2 |
| 165 | sesaminol | 2 |
| 166 | slow-myofibril | 2 |
| 167 | smtc | 2 |
| 168 | sulphachloropyridazine | 2 |
| 169 | sunesis | 2 |
| 170 | three-tesla | 2 |
| 171 | trappers | 2 |
| 172 | urgence | 2 |
| 173 | val342 | 2 |
| 174 | vigconic | 2 |
| 175 | wiry | 2 |
| 176 | wrightides | 2 |
| 177 | zar | 2 |
| 178 | zefat | 2 |
| 179 | znf361 | 2 |
| 180 | 'dha | 1 |
| 181 | 'galantamine | 1 |
| 182 | 'pharmacokinetics | 1 |
| 183 | 'transradial | 1 |
| 184 | -3.357 | 1 |
| 185 | -80.50 | 1 |
| 186 | -a251t | 1 |
| 187 | 0.002-0 | 1 |
| 188 | 0.002k | 1 |
| 189 | 0.02g/kg | 1 |
| 190 | 0.14-0.03 | 1 |
| 191 | 0.22.mpcwp2 | 1 |
| 192 | 0.71/0.53 | 1 |
| 193 | 0·342 | 1 |
| 194 | 0·429 | 1 |
| 195 | 0·459 | 1 |
| 196 | 1.0533 | 1 |
| 197 | 1.071k | 1 |
| 198 | 1.12/0.59 | 1 |
| 199 | 1.25±2.71 | 1 |
| 200 | 1.35/0.71 | 1 |
| 201 | 1.47/0.65 | 1 |
| 202 | 1.50±2.64 | 1 |
| 203 | 1.540 | 1 |
| 204 | 1.639 | 1 |
| 205 | 1.718 | 1 |
| 206 | 1.810 | 1 |
| 207 | 10.0g | 1 |
| 208 | 12·32 | 1 |
| 209 | 14.565 | 1 |
| 210 | 2.384 | 1 |
| 211 | 2.436 | 1 |
| 212 | 2.904 | 1 |
| 213 | 2.966 | 1 |
| 214 | 277,104 | 1 |
| 215 | 2·170 | 1 |
| 216 | 3,7,3',5'-tetramethyl | 1 |
| 217 | 3.373 | 1 |
| 218 | 3.5g/kg | 1 |
| 219 | 3.627 | 1 |
| 220 | 3.882 | 1 |
| 221 | 34.273 | 1 |
| 222 | 43·65 | 1 |
| 223 | 47.761 | 1 |
| 224 | 5.5572 | 1 |
| 225 | 5422.4+/-2031.5 | 1 |
| 226 | 5·50 | 1 |
| 227 | 6-c-l-alpha-arabinopyranosyl-8-c-beta-d-glucopyranosyl | 1 |
| 228 | 7.6+/-1.4** | 1 |
| 229 | 75g/a | 1 |
| 230 | 8.59-8.70 | 1 |
| 231 | 8.736 | 1 |
| 232 | 82.9/86.3 | 1 |
| 233 | a=76.638 | 1 |
| 234 | a=b=135.4 | 1 |
| 235 | a=b=157.3 | 1 |
| 236 | a=b=74.5 | 1 |
| 237 | algna | 1 |
| 238 | anti-lhcgr | 1 |
| 239 | assessed-retention | 1 |
| 240 | avf2119g | 1 |
| 241 | bacitracin-purified | 1 |
| 242 | bactris | 1 |
| 243 | behaviourism | 1 |
| 244 | bio-merieux | 1 |
| 245 | blotchy | 1 |
| 246 | brla | 1 |
| 247 | brower | 1 |
| 248 | c-maf | 1 |
| 249 | c.83_84deltg | 1 |
| 250 | c74s | 1 |
| 251 | caco3and | 1 |
| 252 | cardio-hemodynamic | 1 |
| 253 | carpomya | 1 |
| 254 | cascabella | 1 |
| 255 | cefaloridine | 1 |
| 256 | cepts | 1 |
| 257 | cochinchina | 1 |
| 258 | combined-gender | 1 |
| 259 | consclusions.a | 1 |
| 260 | consensus-2000 | 1 |
| 261 | coronagraph | 1 |
| 262 | cp-19k | 1 |
| 263 | cp-99,219 | 1 |
| 264 | cpsf-160 | 1 |
| 265 | cw*0701/1202 | 1 |
| 266 | df508 | 1 |
| 267 | dihydroxyhydrocinnamic | 1 |
| 268 | donetsk | 1 |
| 269 | e-series | 1 |
| 270 | eldana | 1 |
| 271 | epi-a | 1 |
| 272 | erysipelas-like | 1 |
| 273 | fevillea | 1 |
| 274 | flexners | 1 |
| 275 | fronto-temporally | 1 |
| 276 | g266c | 1 |
| 277 | h69fsdelac | 1 |
| 278 | hairyvein | 1 |
| 279 | handmix/lentulo | 1 |
| 280 | heraeus-kulzer | 1 |
| 281 | hla-b8 | 1 |
| 282 | hsp90α-antagonist | 1 |
| 283 | hydergin* | 1 |
| 284 | hyper-prolactinaemia | 1 |
| 285 | imiquimod-untreated | 1 |
| 286 | infant/premature | 1 |
| 287 | ivoclar/vivadent | 1 |
| 288 | iγ | 1 |
| 289 | k101q | 1 |
| 290 | l-or | 1 |
| 291 | l1-9 | 1 |
| 292 | lasan | 1 |
| 293 | lightness/darkness- | 1 |
| 294 | manghaslin | 1 |
| 295 | metronidazole-related | 1 |
| 296 | micro-incubator | 1 |
| 297 | molecule-frame | 1 |
| 298 | muhajir | 1 |
| 299 | nct00264953 | 1 |
| 300 | non-smokers/smokers | 1 |
| 301 | nontransient | 1 |
| 302 | obatoclax-related | 1 |
| 303 | oddar | 1 |
| 304 | otibazo | 1 |
| 305 | p.arg95* | 1 |
| 306 | p.n902n | 1 |
| 307 | p:0.4 | 1 |
| 308 | pain* | 1 |
| 309 | pastinaca | 1 |
| 310 | pectinolytic | 1 |
| 311 | pl7336 | 1 |
| 312 | pokines | 1 |
| 313 | postradioiodine | 1 |
| 314 | pp1586-pp1585 | 1 |
| 315 | progenika | 1 |
| 316 | pulsoxymetry | 1 |
| 317 | reeclampsia | 1 |
| 318 | results-postoperative | 1 |
| 319 | risk-i.e. | 1 |
| 320 | rs/brazil | 1 |
| 321 | rs4646953 | 1 |
| 322 | safety/mortality | 1 |
| 323 | statin* | 1 |
| 324 | sttr6 | 1 |
| 325 | toxicomania | 1 |
| 326 | twenty-millisecond | 1 |
| 327 | unsponsored-study | 1 |
| 328 | uv-resistant | 1 |
| 329 | vallés | 1 |
| 330 | vinpocetin* | 1 |
| 331 | weird | 1 |
| 332 | werep_aix | 1 |
| 333 | world-cat | 1 |
| 334 | £787 | 1 |
| 1 | 'arginine | 2 |
| 2 | 'dha | 1 |
| 3 | 'galantamine | 1 |
| 4 | 'labour | 2 |
| 5 | 'pharmacokinetics | 1 |
| 6 | 'testosterone | 2 |
| 7 | 'transradial | 1 |
| 8 | -3.357 | 1 |
| 9 | -480 | 2 |
| 10 | -80.50 | 1 |
| 11 | -a251t | 1 |
| 12 | 0.002-0 | 1 |
| 13 | 0.002k | 1 |
| 14 | 0.02g/kg | 1 |
| 15 | 0.14-0.03 | 1 |
| 16 | 0.22.mpcwp2 | 1 |
| 17 | 0.71/0.53 | 1 |
| 18 | 0·342 | 1 |
| 19 | 0·429 | 1 |
| 20 | 0·459 | 1 |
| 21 | 1,650°c | 2 |
| 22 | 1.0533 | 1 |
| 23 | 1.071k | 1 |
| 24 | 1.09-3.03 | 2 |
| 25 | 1.12/0.59 | 1 |
| 26 | 1.25±2.71 | 1 |
| 27 | 1.35/0.71 | 1 |
| 28 | 1.47/0.65 | 1 |
| 29 | 1.50±2.64 | 1 |
| 30 | 1.540 | 1 |
| 31 | 1.639 | 1 |
| 32 | 1.718 | 1 |
| 33 | 1.810 | 1 |
| 34 | 10.0g | 1 |
| 35 | 10.478 | 2 |
| 36 | 12·32 | 1 |
| 37 | 14-3-3μ-1 | 2 |
| 38 | 14.565 | 1 |
| 39 | 2'-deoxyadenosine | 2 |
| 40 | 2-4.99 | 2 |
| 41 | 2-hydroxy-4-methoxybenzaldehyde | 2 |
| 42 | 2-moderate | 2 |
| 43 | 2-secondary | 2 |
| 44 | 2.061 | 2 |
| 45 | 2.384 | 1 |
| 46 | 2.436 | 1 |
| 47 | 2.904 | 1 |
| 48 | 2.966 | 1 |
| 49 | 200j | 2 |
| 50 | 277,104 | 1 |
| 51 | 2·170 | 1 |
| 52 | 3,7,3',5'-tetramethyl | 1 |
| 53 | 3-ost-5 | 2 |
| 54 | 3.373 | 1 |
| 55 | 3.5g/kg | 1 |
| 56 | 3.627 | 1 |
| 57 | 3.882 | 1 |
| 58 | 34.273 | 1 |
| 59 | 43·65 | 1 |
| 60 | 47.761 | 1 |
| 61 | 4rcts | 4 |
| 62 | 5,6-eet | 5 |
| 63 | 5,859 | 2 |
| 64 | 5.5572 | 1 |
| 65 | 5422.4+/-2031.5 | 1 |
| 66 | 5·50 | 1 |
| 67 | 6,900 | 2 |
| 68 | 6-c-l-alpha-arabinopyranosyl-8-c-beta-d-glucopyranosyl | 1 |
| 69 | 7.6+/-1.4** | 1 |
| 70 | 75g/a | 1 |
| 71 | 8.59-8.70 | 1 |
| 72 | 8.736 | 1 |
| 73 | 82.9/86.3 | 1 |
| 74 | 84:16 | 2 |
| 75 | 8br-camp | 2 |
| 76 | a+/a- | 6 |
| 77 | a=76.638 | 1 |
| 78 | a=b=135.4 | 1 |
| 79 | a=b=157.3 | 1 |
| 80 | a=b=74.5 | 1 |
| 81 | aa/ga | 2 |
| 82 | afe-0602 | 2 |
| 83 | agaricales | 2 |
| 84 | airex | 2 |
| 85 | algna | 1 |
| 86 | amnioscopy | 3 |
| 87 | anti-lhcgr | 1 |
| 88 | antiadrenergics | 3 |
| 89 | antony | 6 |
| 90 | apolipoprotein-a | 2 |
| 91 | appending | 3 |
| 92 | arg300 | 3 |
| 93 | assessed-retention | 1 |
| 94 | avf2119g | 1 |
| 95 | azd2858 | 3 |
| 96 | azorellanol | 2 |
| 97 | b-9-3 | 3 |
| 98 | bacitracin-purified | 1 |
| 99 | bactris | 1 |
| 100 | behaviourism | 1 |
| 101 | beside | 231 |
| 102 | besides | 1,940 |
| 103 | bilthoven | 2 |
| 104 | bio-merieux | 1 |
| 105 | blotchy | 1 |
| 106 | boehringer-ingelheim | 4 |
| 107 | brachial-knee | 2 |
| 108 | brat-mediated | 3 |
| 109 | brla | 1 |
| 110 | brower | 1 |
| 111 | brownianism | 2 |
| 112 | bsb-33 | 2 |
| 113 | butanaldehyde | 2 |
| 114 | c-maf | 1 |
| 115 | c.83_84deltg | 1 |
| 116 | c74s | 1 |
| 117 | caco3and | 1 |
| 118 | caism/unicamp | 2 |
| 119 | caki-2 | 2 |
| 120 | cardio-hemodynamic | 1 |
| 121 | carpomya | 1 |
| 122 | cascabella | 1 |
| 123 | cd200r | 2 |
| 124 | cd8+cd3+ | 2 |
| 125 | cefaloridine | 1 |
| 126 | cefalosporines | 3 |
| 127 | cepts | 1 |
| 128 | cij-3-2f | 8 |
| 129 | cochinchina | 1 |
| 130 | combined-gender | 1 |
| 131 | consclusions.a | 1 |
| 132 | consensus-2000 | 1 |
| 133 | continenticola | 2 |
| 134 | coronagraph | 1 |
| 135 | cp-19k | 1 |
| 136 | cp-99,219 | 1 |
| 137 | cpsf-160 | 1 |
| 138 | cw*0701/1202 | 1 |
| 139 | cyclind2 | 2 |
| 140 | d67n | 2 |
| 141 | delphinapterus | 2 |
| 142 | delta-t | 2 |
| 143 | demark | 2 |
| 144 | df508 | 1 |
| 145 | diafiltered | 2 |
| 146 | dihydroxyhydrocinnamic | 1 |
| 147 | donetsk | 1 |
| 148 | dover | 4 |
| 149 | dpb1 | 2 |
| 150 | e-series | 1 |
| 151 | eldana | 1 |
| 152 | eloasthmin | 2 |
| 153 | epi-a | 1 |
| 154 | eryngium | 7 |
| 155 | erysipelas-like | 1 |
| 156 | estromineral | 5 |
| 157 | ethylparaben | 3 |
| 158 | etiology/harm | 2 |
| 159 | fakes | 3 |
| 160 | fam102a | 2 |
| 161 | famously | 3 |
| 162 | favus | 3 |
| 163 | fevillea | 1 |
| 164 | filipinos | 5 |
| 165 | flexners | 1 |
| 166 | fluidigm | 2 |
| 167 | free-contact | 2 |
| 168 | fronto-temporally | 1 |
| 169 | g266c | 1 |
| 170 | galanthamin* | 3 |
| 171 | gb31 | 2 |
| 172 | geomagic | 3 |
| 173 | githago | 5 |
| 174 | gnawing | 2 |
| 175 | graviola | 2 |
| 176 | gsk1360707 | 2 |
| 177 | gualou | 3 |
| 178 | h69fsdelac | 1 |
| 179 | hairyvein | 1 |
| 180 | handmix/lentulo | 1 |
| 181 | heptachlor | 13 |
| 182 | heraeus-kulzer | 1 |
| 183 | high-oil | 3 |
| 184 | high-residue | 2 |
| 185 | hirsch | 5 |
| 186 | hla-b8 | 1 |
| 187 | hot-extruded | 2 |
| 188 | hsp90α-antagonist | 1 |
| 189 | hydergin* | 1 |
| 190 | hyper-prolactinaemia | 1 |
| 191 | hyponosognosic | 2 |
| 192 | il1b-511 | 3 |
| 193 | imiquimod-untreated | 1 |
| 194 | implementation-focused | 2 |
| 195 | infant/premature | 1 |
| 196 | inhibitor-kappabalpha | 2 |
| 197 | inodilation | 2 |
| 198 | interphasal | 2 |
| 199 | is20 | 2 |
| 200 | isomontanolide | 2 |
| 201 | isrctn08609907 | 2 |
| 202 | isrctn51688713 | 2 |
| 203 | ivoclar/vivadent | 1 |
| 204 | ixerisoside | 2 |
| 205 | iγ | 1 |
| 206 | j.b. | 3 |
| 207 | j.p. | 3 |
| 208 | k101q | 1 |
| 209 | kineflex/c | 2 |
| 210 | knitting | 3 |
| 211 | l-or | 1 |
| 212 | l1-9 | 1 |
| 213 | l428 | 2 |
| 214 | lasan | 1 |
| 215 | leary | 2 |
| 216 | less-lethal | 4 |
| 217 | light-chain-only | 2 |
| 218 | lightness/darkness- | 1 |
| 219 | lilopristone | 3 |
| 220 | limpidity | 2 |
| 221 | lineage-negative | 2 |
| 222 | low-sfa | 2 |
| 223 | ltpd471-626 | 2 |
| 224 | mahwah | 3 |
| 225 | manghaslin | 1 |
| 226 | maplike | 2 |
| 227 | melsungen | 19 |
| 228 | metronidazole-related | 1 |
| 229 | micro-incubator | 1 |
| 230 | minami | 3 |
| 231 | minibestest | 2 |
| 232 | molecule-frame | 1 |
| 233 | mono-arthritis | 2 |
| 234 | monoselect | 2 |
| 235 | mpa-glucuronide | 2 |
| 236 | mtor-driven | 2 |
| 237 | muhajir | 1 |
| 238 | møller | 3 |
| 239 | n.u. | 2 |
| 240 | namely | 2,201 |
| 241 | nceo2-m | 3 |
| 242 | nct00264953 | 1 |
| 243 | newell | 2 |
| 244 | ng/ml·h | 5 |
| 245 | nlrp1 | 2 |
| 246 | non-aluminium | 2 |
| 247 | non-consulted | 3 |
| 248 | non-fumigatus | 2 |
| 249 | non-smokers/smokers | 1 |
| 250 | non-sporulating | 4 |
| 251 | noneuphoric | 2 |
| 252 | nontender | 6 |
| 253 | nontransient | 1 |
| 254 | notably | 1,660 |
| 255 | notwithstanding | 181 |
| 256 | np25 | 5 |
| 257 | ns-t-c₃₈₀ | 2 |
| 258 | o-tyrosine | 3 |
| 259 | obatoclax-related | 1 |
| 260 | observer-independent | 2 |
| 261 | oddar | 1 |
| 262 | ongoing/delivered | 4 |
| 263 | optical-fiber-based | 2 |
| 264 | otibazo | 1 |
| 265 | p.arg95* | 1 |
| 266 | p.asp845glu | 2 |
| 267 | p.n902n | 1 |
| 268 | p:0.4 | 1 |
| 269 | pain* | 1 |
| 270 | pastinaca | 1 |
| 271 | pectinolytic | 1 |
| 272 | pl7336 | 1 |
| 273 | placebo-matched | 4 |
| 274 | pokines | 1 |
| 275 | polymorphum | 2 |
| 276 | post-measles | 2 |
| 277 | post-thc | 2 |
| 278 | postradioiodine | 1 |
| 279 | pp1586-pp1585 | 1 |
| 280 | premera | 2 |
| 281 | progenika | 1 |
| 282 | pulsoxymetry | 1 |
| 283 | punjab-96 | 2 |
| 284 | r1441c/g/h | 2 |
| 285 | rahimi | 2 |
| 286 | rarb | 2 |
| 287 | reeclampsia | 1 |
| 288 | repackaged | 3 |
| 289 | resented | 2 |
| 290 | results-postoperative | 1 |
| 291 | risk-i.e. | 1 |
| 292 | ros5 | 4 |
| 293 | rs/brazil | 1 |
| 294 | rs2728127 | 2 |
| 295 | rs28357094 | 2 |
| 296 | rs4646953 | 1 |
| 297 | rs9138 | 2 |
| 298 | rsbv | 3 |
| 299 | safety/mortality | 1 |
| 300 | secant | 3 |
| 301 | selenoneine | 2 |
| 302 | sesaminol | 2 |
| 303 | slow-myofibril | 2 |
| 304 | smad-1/-5/-8 | 3 |
| 305 | smtc | 2 |
| 306 | statin* | 1 |
| 307 | step-up/over | 3 |
| 308 | sttr6 | 1 |
| 309 | styrax | 3 |
| 310 | sulphachloropyridazine | 2 |
| 311 | sunesis | 2 |
| 312 | three-tesla | 2 |
| 313 | toxicomania | 1 |
| 314 | trappers | 2 |
| 315 | twenty-millisecond | 1 |
| 316 | unsponsored-study | 1 |
| 317 | urgence | 2 |
| 318 | uv-resistant | 1 |
| 319 | val342 | 2 |
| 320 | vallés | 1 |
| 321 | vigconic | 2 |
| 322 | vinpocetin* | 1 |
| 323 | viz. | 90 |
| 324 | vp1.15 | 3 |
| 325 | weird | 1 |
| 326 | werep_aix | 1 |
| 327 | wiry | 2 |
| 328 | world-cat | 1 |
| 329 | wrightides | 2 |
| 330 | www.clincaltrials.gov | 3 |
| 331 | zar | 2 |
| 332 | zefat | 2 |
| 333 | znf361 | 2 |
| 334 | £787 | 1 |
| 1 | 7.6+/-1.4** | 1 |
| 2 | p.arg95* | 1 |
| 3 | pain* | 1 |
| 4 | hydergin* | 1 |
| 5 | galanthamin* | 3 |
| 6 | statin* | 1 |
| 7 | vinpocetin* | 1 |
| 8 | cd8+cd3+ | 2 |
| 9 | a+/a- | 6 |
| 10 | lightness/darkness- | 1 |
| 11 | j.b. | 3 |
| 12 | risk-i.e. | 1 |
| 13 | j.p. | 3 |
| 14 | n.u. | 2 |
| 15 | viz. | 90 |
| 16 | 0.002-0 | 1 |
| 17 | consensus-2000 | 1 |
| 18 | arg300 | 3 |
| 19 | 6,900 | 2 |
| 20 | 1.810 | 1 |
| 21 | is20 | 2 |
| 22 | 1.540 | 1 |
| 23 | -80.50 | 1 |
| 24 | 5·50 | 1 |
| 25 | cpsf-160 | 1 |
| 26 | 8.59-8.70 | 1 |
| 27 | 2·170 | 1 |
| 28 | -480 | 2 |
| 29 | 14-3-3μ-1 | 2 |
| 30 | il1b-511 | 3 |
| 31 | gb31 | 2 |
| 32 | 2.061 | 2 |
| 33 | znf361 | 2 |
| 34 | 47.761 | 1 |
| 35 | 1.35/0.71 | 1 |
| 36 | 1.25±2.71 | 1 |
| 37 | dpb1 | 2 |
| 38 | nlrp1 | 2 |
| 39 | caki-2 | 2 |
| 40 | cw*0701/1202 | 1 |
| 41 | afe-0602 | 2 |
| 42 | 12·32 | 1 |
| 43 | val342 | 2 |
| 44 | 0·342 | 1 |
| 45 | 5.5572 | 1 |
| 46 | 3.882 | 1 |
| 47 | cyclind2 | 2 |
| 48 | 0.22.mpcwp2 | 1 |
| 49 | b-9-3 | 3 |
| 50 | 82.9/86.3 | 1 |
| 51 | a=b=157.3 | 1 |
| 52 | 0.14-0.03 | 1 |
| 53 | 1.09-3.03 | 2 |
| 54 | isrctn51688713 | 2 |
| 55 | bsb-33 | 2 |
| 56 | 1.0533 | 1 |
| 57 | 0.71/0.53 | 1 |
| 58 | nct00264953 | 1 |
| 59 | rs4646953 | 1 |
| 60 | 34.273 | 1 |
| 61 | 3.373 | 1 |
| 62 | p:0.4 | 1 |
| 63 | a=b=135.4 | 1 |
| 64 | 277,104 | 1 |
| 65 | 2.904 | 1 |
| 66 | 1.50±2.64 | 1 |
| 67 | 2.384 | 1 |
| 68 | rs28357094 | 2 |
| 69 | 3-ost-5 | 2 |
| 70 | 5422.4+/-2031.5 | 1 |
| 71 | a=b=74.5 | 1 |
| 72 | vp1.15 | 3 |
| 73 | np25 | 5 |
| 74 | 1.47/0.65 | 1 |
| 75 | 14.565 | 1 |
| 76 | 43·65 | 1 |
| 77 | pp1586-pp1585 | 1 |
| 78 | ros5 | 4 |
| 79 | 84:16 | 2 |
| 80 | ltpd471-626 | 2 |
| 81 | pl7336 | 1 |
| 82 | 2.436 | 1 |
| 83 | 8.736 | 1 |
| 84 | 2.966 | 1 |
| 85 | punjab-96 | 2 |
| 86 | sttr6 | 1 |
| 87 | gsk1360707 | 2 |
| 88 | isrctn08609907 | 2 |
| 89 | rs2728127 | 2 |
| 90 | 3.627 | 1 |
| 91 | -3.357 | 1 |
| 92 | £787 | 1 |
| 93 | smad-1/-5/-8 | 3 |
| 94 | df508 | 1 |
| 95 | 1.718 | 1 |
| 96 | l428 | 2 |
| 97 | rs9138 | 2 |
| 98 | a=76.638 | 1 |
| 99 | azd2858 | 3 |
| 100 | 10.478 | 2 |
| 101 | hla-b8 | 1 |
| 102 | l1-9 | 1 |
| 103 | cp-99,219 | 1 |
| 104 | 0·429 | 1 |
| 105 | 1.639 | 1 |
| 106 | 1.12/0.59 | 1 |
| 107 | 0·459 | 1 |
| 108 | 5,859 | 2 |
| 109 | 2-4.99 | 2 |
| 110 | epi-a | 1 |
| 111 | apolipoprotein-a | 2 |
| 112 | consclusions.a | 1 |
| 113 | 75g/a | 1 |
| 114 | fam102a | 2 |
| 115 | pastinaca | 1 |
| 116 | fevillea | 1 |
| 117 | low-sfa | 2 |
| 118 | aa/ga | 2 |
| 119 | 'dha | 1 |
| 120 | inhibitor-kappabalpha | 2 |
| 121 | hyper-prolactinaemia | 1 |
| 122 | toxicomania | 1 |
| 123 | reeclampsia | 1 |
| 124 | progenika | 1 |
| 125 | cascabella | 1 |
| 126 | continenticola | 2 |
| 127 | graviola | 2 |
| 128 | brla | 1 |
| 129 | three-tesla | 2 |
| 130 | eldana | 1 |
| 131 | algna | 1 |
| 132 | cochinchina | 1 |
| 133 | premera | 2 |
| 134 | carpomya | 1 |
| 135 | rarb | 2 |
| 136 | kineflex/c | 2 |
| 137 | g266c | 1 |
| 138 | h69fsdelac | 1 |
| 139 | post-thc | 2 |
| 140 | geomagic | 3 |
| 141 | dihydroxyhydrocinnamic | 1 |
| 142 | cardio-hemodynamic | 1 |
| 143 | vigconic | 2 |
| 144 | noneuphoric | 2 |
| 145 | hyponosognosic | 2 |
| 146 | pectinolytic | 1 |
| 147 | smtc | 2 |
| 148 | 1,650°c | 2 |
| 149 | hot-extruded | 2 |
| 150 | repackaged | 3 |
| 151 | placebo-matched | 4 |
| 152 | bacitracin-purified | 1 |
| 153 | diafiltered | 2 |
| 154 | ongoing/delivered | 4 |
| 155 | optical-fiber-based | 2 |
| 156 | implementation-focused | 2 |
| 157 | imiquimod-untreated | 1 |
| 158 | brat-mediated | 3 |
| 159 | metronidazole-related | 1 |
| 160 | obatoclax-related | 1 |
| 161 | non-consulted | 3 |
| 162 | resented | 2 |
| 163 | caco3and | 1 |
| 164 | twenty-millisecond | 1 |
| 165 | weird | 1 |
| 166 | urgence | 2 |
| 167 | isomontanolide | 2 |
| 168 | mpa-glucuronide | 2 |
| 169 | beside | 231 |
| 170 | ixerisoside | 2 |
| 171 | butanaldehyde | 2 |
| 172 | 2-hydroxy-4-methoxybenzaldehyde | 2 |
| 173 | brachial-knee | 2 |
| 174 | erysipelas-like | 1 |
| 175 | maplike | 2 |
| 176 | molecule-frame | 1 |
| 177 | cefaloridine | 1 |
| 178 | postradioiodine | 1 |
| 179 | selenoneine | 2 |
| 180 | 'galantamine | 1 |
| 181 | 'arginine | 2 |
| 182 | 2'-deoxyadenosine | 2 |
| 183 | o-tyrosine | 3 |
| 184 | sulphachloropyridazine | 2 |
| 185 | 'testosterone | 2 |
| 186 | lilopristone | 3 |
| 187 | infant/premature | 1 |
| 188 | 2-moderate | 2 |
| 189 | high-residue | 2 |
| 190 | lineage-negative | 2 |
| 191 | results-postoperative | 1 |
| 192 | cij-3-2f | 8 |
| 193 | c-maf | 1 |
| 194 | 10.0g | 1 |
| 195 | avf2119g | 1 |
| 196 | 0.02g/kg | 1 |
| 197 | 3.5g/kg | 1 |
| 198 | notwithstanding | 181 |
| 199 | appending | 3 |
| 200 | non-sporulating | 4 |
| 201 | knitting | 3 |
| 202 | gnawing | 2 |
| 203 | c.83_84deltg | 1 |
| 204 | r1441c/g/h | 2 |
| 205 | mahwah | 3 |
| 206 | hirsch | 5 |
| 207 | coronagraph | 1 |
| 208 | ng/ml·h | 5 |
| 209 | minami | 3 |
| 210 | rahimi | 2 |
| 211 | 200j | 2 |
| 212 | 1.071k | 1 |
| 213 | 0.002k | 1 |
| 214 | cp-19k | 1 |
| 215 | demark | 2 |
| 216 | donetsk | 1 |
| 217 | less-lethal | 4 |
| 218 | 'transradial | 1 |
| 219 | estromineral | 5 |
| 220 | interphasal | 2 |
| 221 | high-oil | 3 |
| 222 | slow-myofibril | 2 |
| 223 | rs/brazil | 1 |
| 224 | newell | 2 |
| 225 | azorellanol | 2 |
| 226 | sesaminol | 2 |
| 227 | 3,7,3',5'-tetramethyl | 1 |
| 228 | 6-c-l-alpha-arabinopyranosyl-8-c-beta-d-glucopyranosyl | 1 |
| 229 | nceo2-m | 3 |
| 230 | fluidigm | 2 |
| 231 | boehringer-ingelheim | 4 |
| 232 | etiology/harm | 2 |
| 233 | brownianism | 2 |
| 234 | behaviourism | 1 |
| 235 | polymorphum | 2 |
| 236 | eryngium | 7 |
| 237 | non-aluminium | 2 |
| 238 | p.n902n | 1 |
| 239 | d67n | 2 |
| 240 | lasan | 1 |
| 241 | ethylparaben | 3 |
| 242 | melsungen | 19 |
| 243 | mtor-driven | 2 |
| 244 | bilthoven | 2 |
| 245 | hairyvein | 1 |
| 246 | manghaslin | 1 |
| 247 | eloasthmin | 2 |
| 248 | inodilation | 2 |
| 249 | assessed-retention | 1 |
| 250 | githago | 5 |
| 251 | handmix/lentulo | 1 |
| 252 | otibazo | 1 |
| 253 | 8br-camp | 2 |
| 254 | caism/unicamp | 2 |
| 255 | k101q | 1 |
| 256 | cd200r | 2 |
| 257 | oddar | 1 |
| 258 | zar | 2 |
| 259 | combined-gender | 1 |
| 260 | nontender | 6 |
| 261 | møller | 3 |
| 262 | step-up/over | 3 |
| 263 | dover | 4 |
| 264 | brower | 1 |
| 265 | heraeus-kulzer | 1 |
| 266 | anti-lhcgr | 1 |
| 267 | muhajir | 1 |
| 268 | l-or | 1 |
| 269 | heptachlor | 13 |
| 270 | micro-incubator | 1 |
| 271 | 'labour | 2 |
| 272 | c74s | 1 |
| 273 | antiadrenergics | 3 |
| 274 | 'pharmacokinetics | 1 |
| 275 | besides | 1,940 |
| 276 | wrightides | 2 |
| 277 | e-series | 1 |
| 278 | fakes | 3 |
| 279 | agaricales | 2 |
| 280 | post-measles | 2 |
| 281 | pokines | 1 |
| 282 | cefalosporines | 3 |
| 283 | bactris | 1 |
| 284 | sunesis | 2 |
| 285 | mono-arthritis | 2 |
| 286 | filipinos | 5 |
| 287 | non-smokers/smokers | 1 |
| 288 | flexners | 1 |
| 289 | trappers | 2 |
| 290 | 4rcts | 4 |
| 291 | cepts | 1 |
| 292 | delphinapterus | 2 |
| 293 | non-fumigatus | 2 |
| 294 | favus | 3 |
| 295 | vallés | 1 |
| 296 | delta-t | 2 |
| 297 | -a251t | 1 |
| 298 | world-cat | 1 |
| 299 | zefat | 2 |
| 300 | free-contact | 2 |
| 301 | monoselect | 2 |
| 302 | 5,6-eet | 5 |
| 303 | secant | 3 |
| 304 | uv-resistant | 1 |
| 305 | ivoclar/vivadent | 1 |
| 306 | observer-independent | 2 |
| 307 | nontransient | 1 |
| 308 | minibestest | 2 |
| 309 | hsp90α-antagonist | 1 |
| 310 | p.asp845glu | 2 |
| 311 | gualou | 3 |
| 312 | rsbv | 3 |
| 313 | www.clincaltrials.gov | 3 |
| 314 | styrax | 3 |
| 315 | airex | 2 |
| 316 | werep_aix | 1 |
| 317 | bio-merieux | 1 |
| 318 | unsponsored-study | 1 |
| 319 | blotchy | 1 |
| 320 | notably | 1,660 |
| 321 | namely | 2,201 |
| 322 | fronto-temporally | 1 |
| 323 | light-chain-only | 2 |
| 324 | famously | 3 |
| 325 | antony | 6 |
| 326 | amnioscopy | 3 |
| 327 | 2-secondary | 2 |
| 328 | leary | 2 |
| 329 | wiry | 2 |
| 330 | pulsoxymetry | 1 |
| 331 | limpidity | 2 |
| 332 | safety/mortality | 1 |
| 333 | ns-t-c₃₈₀ | 2 |
| 334 | iγ | 1 |